Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 18

Porokeratotic Eccrine Ostial and Dermal Duct Nevus: A Report of Rare Late-Onset Solitary Lesion

Authors Tejapira K ORCID logo, Suchonwanit P ORCID logo

Received 22 December 2024

Accepted for publication 27 March 2025

Published 3 April 2025 Volume 2025:18 Pages 791—796

DOI https://doi.org/10.2147/CCID.S513737

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Michela Starace



Kasama Tejapira, Poonkiat Suchonwanit

Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

Correspondence: Poonkiat Suchonwanit, Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 270 Rama VI Road, Ratchathewi, Bangkok, 10400, Thailand, Tel +66-2-2011141, Fax +66-2-201-1211 ext 4, Email [email protected]

Abstract: Porokeratotic eccrine ostial and dermal duct nevus (PEODDN) is a rare dermatological disorder with fewer than 100 reported cases. It is characterized by abnormal keratinization over the dilated acrosyringium, and is hypothesized to involve somatic mosaicism of the GJB2 gene. Typically presenting in early childhood with linearly distributed hyperkeratotic papules along the Blaschko line, PEODDN predominantly affects palms and soles. We report an atypical case of PEODDN in a 64-year-old woman who presented with an asymptomatic solitary nodule on her left foot that had been present for three months. Histopathological examination confirmed the diagnosis and revealed a characteristic cornoid lamella overlying the dilated acrosyringium. The lesion was successfully treated with a CO2 laser, with complete resolution and no recurrence at one-month follow-up. This case highlights the importance of considering PEODDN in the differential diagnosis of solitary lesion in atypical locations, even in older adults, and contributes to the limited literature on the late-onset solitary presentation of this rare condition. Our comprehensive review of the literature provides insights into the pathogenesis, clinical variations, associated conditions, and treatment options of PEODDN, with the aim of guiding clinicians in managing this uncommon entity.

Keywords: acrosyringial duct, comedo nevus, Connexin26, eccrine nevus, porokeratotic adnexal ostial nevus, porokeratotic eccrine and hair follicle nevus

Introduction

Porokeratotic eccrine ostial and dermal duct nevus (PEODDN), first described by Marsden et al in 1979 as “comedo nevus”, is a disorder of abnormal keratinization in the eccrine sweat gland, specifically over the dilated acrosyringium.1,2 The term was later changed to “PEODDN” to better reflect its histopathological features.3 While typically congenital or early childhood onset involving multiple, linearly distributed, hyperkeratotic papules predominantly affecting the palms and soles, rare cases of adult-onset PEODDN and solitary lesion have been reported, highlighting the variable clinical spectrum of this condition. The definitive diagnosis of PEODDN relies on the histopathological hallmark of the cornoid lamella overlying dilated eccrine acrosyringia.3

The etiology of PEODDN remains unclear. However, recent genetic studies have provided valuable insights into its pathogenesis, with implications for both diagnostic and therapeutic approaches. Herein, we present an atypical case of late-onset solitary PEODDN in a 64-year-old woman. By describing this unusual presentation and providing a comprehensive review of the literature, we aimed to enhance our understanding of the clinical variability of PEODDN and guide clinicians in its diagnosis and management.

Case Presentation

A 64-year-old woman presented with a solitary nodule on the medial side of her left foot that had been present for three months. The patient reported that the lesion had gradually increased in size, but remained asymptomatic throughout this period. The medical history included asthma and systemic sclerosis with interstitial lung fibrosis. The patient was under regular follow-up with a rheumatologist and a pulmonologist, and her condition was stable. The patient denied having a family history of similar skin lesions or other hereditary skin conditions. Physical examination revealed a solitary, well-demarcated, brownish hyperkeratotic papule on the left foot (Figure 1A). The lesion had a slight verrucous surface with central scaling (Figure 1B). There were no signs of inflammation, and no similar lesions were found elsewhere in the body. According to the presentation, the differential diagnoses included verruca vulgaris, prurigo nodularis, dermatofibroma, eccrine poroma, and basal cell carcinoma.

Figure 1 Clinical presentation: (A) solitary, well-demarcated, brownish, hyperkeratotic papule; (B) close-up picture showing slightly verrucous surface with central scaling.

Given the atypical presentation and location of the lesion, punch biopsy was performed for diagnosis. Histopathological examination revealed a vertical column of parakeratosis overlying a dilated acrosyringium, consistent with a cornoid lamella (Figure 2A). The epidermis exhibited dwellings, absence of a subjacent granular layer, and perinuclear halos (Figure 2B). The underlying dermis and subcutis were both normal. These histopathological features were consistent with those observed in PEODDN. Based on the clinical presentation and histopathological findings, late-onset solitary PEODDN was diagnosed. After discussing the treatment options with the patient, we decided to proceed with CO2 laser therapy because of its reported efficacy in previous cases of PEODDN and the localized nature of the lesion. At the one-month follow-up visit, the treated area healed well, with minimal residual erythema and no evidence of recurrence. The patient reported satisfaction with cosmetic outcomes.

Figure 2 Histopathological features (hematoxylin-eosin staining): (A) vertical column of parakeratosis overlying dilated acrosyringium (arrow), forming characteristic cornoid lamella (original magnification x100); (B) epidermal dwelling with absence of granular layer (original magnification x400).

Discussion

Our case presents unique features that contribute to the existing literature on PEODDN. First, late onset at 64 years of age is unusual because PEODDN typically presents in early childhood or is congenital. Second, the solitary nature of the lesion contrasts with the more common linear or systematized distribution along the Blaschko lines. To identify previous reports of solitary PEODDN, we conducted a comprehensive literature search using PubMed and Scopus databases from inception to December 2024. The search terms included “porokeratotic eccrine ostial and dermal duct nevus”, “PEODDN”, “eccrine nevus”, “porokeratotic adnexal ostial nevus”, “comedo nevus”, “solitary”, and “adult-onset”. Additional references were identified through manual searches of the reference lists of relevant articles. This search strategy identified only three previously reported cases of adult-onset solitary PEODDN, as summarized in Table 1.4–6

Table 1 Previously Reported Cases of Porokeratotic Eccrine Ostial and Dermal Duct Nevus Presenting With Solitary Lesion

The exact prevalence of PEODDN remains unknown, further emphasizing its uncommon nature. The rarity of PEODDN is evident in the limited number of reported cases. To date, fewer than 100 cases have been documented in the literature, making it a challenging condition to diagnose and manage.5 The majority of cases present with multiple erythematous yellowish keratotic papules with central pits or verrucous-like lesions distributed along the Blaschko lines. The lesions are generally asymptomatic, but mild to moderate itching or intermittent inflammation can occur.7 PEODDN shows no gender predilection and is typically congenital or of childhood onset.5 The disease is primarily unilateral and predominantly involves the palms and soles, although generalized involvement of proximal extremities and trunk has been reported.8–11 Definitive diagnosis of the disease is made according to histopathological characteristics of parakeratotic column of cornoid lamellae overlying dilated or hyperplastic eccrine acrosyringia with subjacent granular layer loss, focal vacuolization of adjacent keratinocyte, and occasionally sparse lymphocytic infiltration.5

It is crucial to differentiate PEODDN from entities with similar clinical presentations, particularly those with malignant potential. Eccrine porocarcinoma is an important differential diagnosis that warrants special attention. Unlike PEODDN, porocarcinoma typically presents with rapid growth, ulceration, bleeding, and may show infiltrative borders. While PEODDN exhibits cornoid lamellae originating from eccrine ducts with benign cytological features, porocarcinoma demonstrates malignant cytological features including nuclear pleomorphism, atypical mitoses, and invasive growth patterns.12 Misdiagnosis could lead to inadequate treatment, as porocarcinoma requires more aggressive management including wide local excision and potential adjuvant therapy.12

Although the pathogenesis of PEODDN remains unclear, recent genetic studies have provided valuable insights. Somatic mosaicism of the GJB2 gene, which encodes the gap junction protein Connexin26, is hypothesized to play a role in this process.13 This finding is particularly interesting given the predominant expression of Connexin26 in the palm, soles, hair follicles, and eccrine sweat glands, which are commonly affected by PEODDN.13–15 The hypothesis that PEODDN represents a mosaic form of keratitis-ichthyosis-deafness (KID) syndrome, as proposed by Lazic et al, further supports the role of GJB2 mutations.13 Both of which share similar histopathological features and involve Connexin26 dysfunction. However, the localized nature of PEODDN contrasts with the generalized involvement in KID syndrome, likely reflecting the timing and extent of somatic mutations during embryonic development.

PEODDN is associated with various cutaneous and systemic conditions; however, the significance of these associations remains unclear. The reported disorders include hearing loss and developmental delay, squamous cell carcinoma, Bowen disease, severe alopecia and onychodysplasia, polyneuropathy and hyperthyroidism, breast hypoplasia, and hemiparesis, seizure and scoliosis.16–21 Rarely, PEODDN was found to coexist with other skin diseases, ie, linear epidermal nevus, calcinosis cutis, psoriasis, and psoriasiform variant of PEODDN.22–26

Treatment of PEODDN remains challenging, with variable responses reported in the literature. Most reported therapies are ineffective, such as keratolytic agents, topical calcipotriol, topical retinoids, topical corticosteroids, systemic retinoids, and cryotherapy.27–29 CO2 lasers, photodynamic therapy, and a combination of erbium and CO2 lasers have shown the most promising results.30,31 Spontaneous resolution has also been reported in some cases.32,33 In our case, we opted for CO2 laser treatment because of its reported efficacy and minimal scarring. The successful outcome at one-month follow-up supports the use of this modality for solitary PEODDN lesion, although a long-term follow-up is necessary to assess recurrence.

Conclusion

This case report highlights the atypical presentation of PEODDN, emphasizing the importance of considering this rare entity in the differential diagnosis of solitary keratotic lesion, even at late-onset and unusual locations. Characteristic histopathological findings are crucial for accurate diagnosis. Our case also provides valuable insights into the pathogenesis, associated conditions, and treatment options for PEODDN. Clinicians should be aware of the diverse manifestations of PEODDN and its potential associations with several conditions. For optimal management of complex cases, a multidisciplinary approach involving dermatologists, plastic surgeons, dermatopathologists, and medical or radiation oncologists can be warranted in cases with extensive involvement, systemic associations, or suspicion of malignancy. Long-term follow-up is recommended for all patients with PEODDN to monitor potential complications and assess the treatment efficacy. We also acknowledge that as a single-case report, our experience has inherent limitations; continued documentation of similar cases will be valuable to further characterize this rare disorder. As our understanding of the genetic basis of PEODDN continues to evolve, future research should focus on elucidating the full spectrum of GJB2 mutations and their functional consequences. Additionally, novel treatment approaches such as targeted therapies based on underlying genetic alterations may offer more effective options.

Ethics Approval and Consent to Participate

This article was conducted in accordance with the principles of the Declaration of Helsinki. Ethical review and approval were not required to publish case details in accordance with local legislation and institutional requirements. Written informed consent was obtained from the patient for publication of this case report and any accompanying images according to our standard institutional rules.

Funding

No sources of funding were used to prepare this manuscript.

Disclosure

The authors declare that this manuscript was prepared in the absence of any commercial or financial relationships that could be construed as potential conflict of interest.

References

1. Llamas-Velasco M, Hilty N, Kempf W. Porokeratotic adnexal ostial naevus: review on the entity and therapeutic approach. J Eur Acad Dermatol Venereol. 2015;29(10):2032–2037. doi:10.1111/jdv.12732

2. Marsden RA, Fleming K, Dawber RP. Comedo naevus of the palm--a sweat duct naevus? Br J Dermatol. 1979;101(6):717–722. doi:10.1111/j.1365-2133.1979.tb05653.x

3. Abell E, Read SI. Porokeratotic eccrine ostial and dermal duct naevus. Br J Dermatol. 1980;103(4):435–441. doi:10.1111/j.1365-2133.1980.tb07268.x

4. Beer K, Medenica M. Solitary truncal porokeratotic eccrine ostial and dermal duct nevus in a sixty-year-old man. Int J Dermatol. 1996;35(2):124–125. doi:10.1111/j.1365-4362.1996.tb03277.x

5. Wang NS, Meola T, Orlow SJ, Kamino H. Porokeratotic eccrine ostial and dermal duct nevus: a report of 2 cases and review of the literature. Am J Dermatopathol. 2009;31(6):582–586. doi:10.1097/DAD.0b013e3181a09b62

6. Arbogast M, Bax D, Paragh G, Bogner PN. Late-onset solitary porokeratotic eccrine ostial and dermal duct nevus. JAAD Case Rep. 2018;4(5):434–436. doi:10.1016/j.jdcr.2017.12.008

7. Bandyopadhyay D, Saha A, Das D, Das A. Porokeratotic eccrine ostial and dermal duct nevus. Indian Dermatol Online J. 2015;6(2):117–119. doi:10.4103/2229-5178.153016

8. Cobb MW, Vidmar DA, Dilaimy MS. Porokeratotic eccrine ostial and dermal duct nevus: a case of systematized involvement. Cutis. 1990;46(6):495–497.

9. Suchonwanit P, Triyangkulsri K, Ploydaeng M, Leerunyakul K. Assessing biophysical and physiological profiles of scalp seborrheic dermatitis in the Thai population. Biomed Res Int. 2019;2019:5128376. doi:10.1155/2019/5128376

10. Murata Y, Nogita T, Kawashima M, Hidano A. Unilateral, systematized, porokeratotic eccrine ostial and dermal duct nevi. J Am Acad Dermatol. 1991;24(2 Pt 1):300–301. doi:10.1016/s0190-9622(08)80618-4

11. Cambiaghi S, Gianotti R, Caputo R. Widespread porokeratotic eccrine ostial and dermal duct nevus along Blaschko lines. Pediatr Dermatol. 2007;24(2):162–167. doi:10.1111/j.1525-1470.2007.00367.x

12. Fionda B, Di Stefani A, Lancellotta V, et al. The role of postoperative radiotherapy in eccrine porocarcinoma: a multidisciplinary systematic review. Eur Rev Med Pharmacol Sci. 2022;26(5):1695–1700. doi:10.26355/eurrev_202203_28238

13. Lazic T, Li Q, Frank M, Uitto J, Zhou LH. Extending the phenotypic spectrum of keratitis-ichthyosis-deafness syndrome: report of a patient with GJB2 (G12R) Connexin 26 mutation and unusual clinical findings. Pediatr Dermatol. 2012;29(3):349–357. doi:10.1111/j.1525-1470.2011.01425.x

14. Easton JA, Donnelly S, Kamps MA, et al. Porokeratotic eccrine nevus may be caused by somatic connexin26 mutations. J Invest Dermatol. 2012;132(9):2184–2191. doi:10.1038/jid.2012.143

15. Levinsohn JL, McNiff JM, Antaya RJ, Choate KA. A somatic p.G45E GJB2 mutation causing porokeratotic eccrine ostial and dermal duct nevus. JAMA Dermatol. 2015;151(6):638–641. doi:10.1001/jamadermatol.2014.5069

16. Jamora MJ, Celis MA. Generalized porokeratotic eccrine ostial and dermal duct nevus associated with deafness. J Am Acad Dermatol. 2008;59(2 Suppl 1):S43–5. doi:10.1016/j.jaad.2007.09.034

17. Khunkhet S, Rattananukrom T, Thanasarnaksorn W, Suchonwanit P. Alopecia induced by autologous fat injection into the temporal area: case report and review of the literature. Case Rep Dermatol. 2019;11(2):150–156. doi:10.1159/000500710

18. Nassiri N, Hansen J. Diffuse squamous cell carcinoma in porokeratotic eccrine ostial and dermal duct nevus. Plast Reconstr Surg. 2009;123(2):87e–88e. doi:10.1097/PRS.0b013e31819596ea

19. Suchonwanit P, Leerunyakul K, Kositkuljorn C. Diagnostic and prognostic values of cutaneous manifestations in COVID-19. Dermatol Ther. 2020;33(4):e13650. doi:10.1111/dth.13650

20. Coras B, Vogt T, Roesch A, Landthaler M, Hohenleutner U. Bowen’s disease on porokeratotic eccrine ostial and dermal duct nevus. Dermatol Surg. 2007;33(4):496–499. doi:10.1111/j.1524-4725.2007.33099.x

21. Rasi A, Tajziechi L. Late-onset porokeratotic eccrine ostial and dermal duct nevus associated with sensory polyneuropathy and hyperthyroidism. Arch Iran Med. 2008;11(2):218–220.

22. Yu HJ, Ko JY, Kwon HM, Kim JS. Linear psoriasis with porokeratotic eccrine ostial and dermal duct nevus. J Am Acad Dermatol. 2004;50(5 Suppl):S81–3. doi:10.1016/s0190-9622(03)02797-x

23. Chanprapaph K, Sutharaphan T, Suchonwanit P. Scalp biophysical characteristics in males with androgenetic alopecia: a comparative study with healthy controls. Clin Interv Aging. 2021;16:781–787. doi:10.2147/cia.S310178

24. Vasudevan B, Sondhi V, Verma R, Neema S. A unique association of unilateral idiopathic calcinosis cutis with ipsilateral porokeratotic eccrine ostial and dermal duct nevus. Pediatr Dermatol. 2015;32(1):e8–12. doi:10.1111/pde.12458

25. Pezoa XE, Nicklas Díaz C, Cárdenas de la Torre C, Romero Gallardo W, Schäffer Villalobos F, González Bombardiere S. Porokeratotic eccrine ostial and dermal duct nevus with linear verrucous epidermal nevus: an unusual association. Int J Dermatol. 2014;53(5):625–627. doi:10.1111/j.1365-4632.2011.05076.x

26. Rattanakaemakorn P, Suchonwanit P. Scalp pruritus: review of the pathogenesis, diagnosis, and management. Biomed Res Int. 2019;2019:1268430. doi:10.1155/2019/1268430

27. Alomran H, Kanitakis J. Adult-onset porokeratotic eccrine ostial and dermal duct nevus: dermatoscopic findings and treatment with tazarotene. Dermatol Online J. 2020;26(2).

28. Vahabi-Amlashi S, Tayyebi Meibodi N, Feli S, Taghavi F. Progressive late-onset porokeratotic eccrine ostial and dermal duct naevus. Australas J Dermatol. 2019;60(4):e333–e334. doi:10.1111/ajd.13040

29. Birol A, Erkek E, Bozdoethan O, Koçak M, Atasoy P. A case of porokeratotic eccrine ostial and dermal duct naevus of late onset. J Eur Acad Dermatol Venereol. 2004;18(5):619–621. doi:10.1111/j.1468-3083.2004.01019.x

30. Del Pozo J, Martínez W, Verea MM, Yebra-Pimentel MT, García-Silva J, Fonseca E. Porokeratotic eccrine ostial and dermal duct naevus: treatment with carbon dioxide laser. Br J Dermatol. 1999;141(6):1144–1145. doi:10.1046/j.1365-2133.1999.03230.x

31. Wong JW, Summers EM, Taylor MB, Harris RM. Porokeratotic eccrine ostial and dermal duct nevus treated with a combination erbium/CO2 laser: a case and brief review. Dermatol Online J. 2011;17(9):10.

32. Mazuecos J, Ortega M, Ríos JJ, Camacho F. Long-term involution of unilateral porokeratotic eccrine ostial and dermal duct naevus. Acta Derm Venereol. 2003;83(2):147–149. doi:10.1080/00015550310007599

33. Petkiewicz S, Baltz J, Cornejo K, Deng A, Wiss K. Widespread presentation and spontaneous regression of porokeratotic eccrine ostial and dermal duct nevus. JAAD Case Rep. 2018;4(10):972–975. doi:10.1016/j.jdcr.2018.08.001

Creative Commons License © 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms and incorporate the Creative Commons Attribution - Non Commercial (unported, 4.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.